OBJECTIVE: Activated mast cells (MCs) release chymase, which can induce vascular smooth muscle cell (VSMC) apoptosis leading to plaque destabilization. Because the mechanism through which MCs release chymase in atherosclerosis is unknown, we studied whether MC-associated VSMC apoptosis is regulated by toll-like receptor 4 (TLR4) signaling. METHODS AND RESULTS: Local recruitment and activation of MCs reduced VSMC content specifically in the cap region of vulnerable plaques in apolipoprotein E knockout mice. Cotreatment with the TLR4 antagonist Bartonella quintana lipopolysaccharide prevented this VSMC loss, suggesting an important role for TLR4 signaling in MC-induced VSMC apoptosis. Coculture of VSMCs with MCs activated by the TLR4 agonist Escherichia coli lipopolysaccharide increased VSMC apoptosis. Apoptosis was inhibited by TLR4 and chymase blockers, indicating that TLR4 signaling is involved in chymase release in MCs. This pathway was mediated via interleukin-6 because interleukin-6 promoted MC-associated VSMC apoptosis, which was inhibited by blocking chymase release. In addition, TLR4 activation in MCs induced interleukin-6 production, which was reduced by preincubation with either B. quintana lipopolysaccharide or an anti-TLR4 antibody. CONCLUSIONS: We show that MCs promote VSMC apoptosis in vivo. In addition, TLR4 signaling is important in chymase release in MCs and, therefore, in plaque destabilization by regulating VSMC apoptosis.
OBJECTIVE: Activated mast cells (MCs) release chymase, which can induce vascular smooth muscle cell (VSMC) apoptosis leading to plaque destabilization. Because the mechanism through which MCs release chymase in atherosclerosis is unknown, we studied whether MC-associated VSMC apoptosis is regulated by toll-like receptor 4 (TLR4) signaling. METHODS AND RESULTS: Local recruitment and activation of MCs reduced VSMC content specifically in the cap region of vulnerable plaques in apolipoprotein E knockout mice. Cotreatment with the TLR4 antagonist Bartonella quintanalipopolysaccharide prevented this VSMC loss, suggesting an important role for TLR4 signaling in MC-induced VSMC apoptosis. Coculture of VSMCs with MCs activated by the TLR4 agonist Escherichia colilipopolysaccharide increased VSMC apoptosis. Apoptosis was inhibited by TLR4 and chymase blockers, indicating that TLR4 signaling is involved in chymase release in MCs. This pathway was mediated via interleukin-6 because interleukin-6 promoted MC-associated VSMC apoptosis, which was inhibited by blocking chymase release. In addition, TLR4 activation in MCs induced interleukin-6 production, which was reduced by preincubation with either B. quintanalipopolysaccharide or an anti-TLR4 antibody. CONCLUSIONS: We show that MCs promote VSMC apoptosis in vivo. In addition, TLR4 signaling is important in chymase release in MCs and, therefore, in plaque destabilization by regulating VSMC apoptosis.
Authors: Jing Wang; Sara Sjöberg; Viviane Tia; Blandine Secco; Han Chen; Min Yang; Galina K Sukhova; Guo-Ping Shi Journal: Atherosclerosis Date: 2013-06-07 Impact factor: 5.162
Authors: Martine Bot; Saskia C A de Jager; Luke MacAleese; H Maxime Lagraauw; Theo J C van Berkel; Paul H A Quax; Johan Kuiper; Ron M A Heeren; Erik A L Biessen; Ilze Bot Journal: J Lipid Res Date: 2013-02-10 Impact factor: 5.922
Authors: Anouk Wezel; Margreet R de Vries; H Maxime Lagraauw; Amanda C Foks; Johan Kuiper; Paul H A Quax; Ilze Bot Journal: J Cell Mol Med Date: 2014-08-15 Impact factor: 5.310
Authors: Anouk Wezel; Margreet R de Vries; Johanna M Maassen; Peter Kip; Erna A Peters; Jacco C Karper; Johan Kuiper; Ilze Bot; Paul H A Quax Journal: Sci Rep Date: 2016-04-07 Impact factor: 4.379
Authors: Jing Wang; Jes S Lindholt; Galina K Sukhova; Michael A Shi; Mingcan Xia; Han Chen; Meixiang Xiang; Aina He; Yi Wang; Na Xiong; Peter Libby; Jian-An Wang; Guo-Ping Shi Journal: EMBO Mol Med Date: 2014-07 Impact factor: 12.137